AusPAR: Rituximab

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

22 September 2015
AusPAR Details
AusPAR
AusPAR: Rituximab (pdf, 897 KB)
AusPAR: Rituximab (docx, 2 MB)
Attachment: Product Information: Rituximab (pdf, 674 KB)
Attachment: Product Information: Rituximab (docx, 226 KB)
Attachment: Extract from Clinical Evaluation Report: Rituximab (pdf, 2 MB)
Attachment: Extract from Clinical Evaluation Report: Rituximab (docx, 3 MB)
Active Ingredient
Rituximab
Product Name
MabThera
Sponsor
Roche Products Pty Ltd
Submission Number
PM-2013-04906-1-3
Submission Type
New dosing schedule
Decision
Approved
AusPAR Date
27 August 2015
Publication Date

22 September 2015
Category: 
Prescription medicines
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/709563